MENU

Stories

Three USC researchers win $4.3 million in awards from California’s stem cell agency

Three scientists from Keck Medicine of USC have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine (CIRM) for research that includes creating a temporary liver for patients, finding novel ways to treat immune disorders and blood diseases, and developing new animal models for heart failure, diabetes and neurodegenerative diseases. The grants, …

The road to a cure for HIV/AIDS

Something wonderful sometimes happens when scientists and the public get together to talk about research. All the jargon, all the technical language falls away, and it becomes instead a conversation between the two groups with most at stake: the people in need of a treatment or cure, and the people trying to develop it. Last …

California’s stem cell agency hosts public meetings with citizens and patients

This summer, leaders from the California Institute for Regenerative Medicine (CIRM) visited Los Angeles, San Diego and San Francisco to consult with citizens and patient advocates in each city. These are the citizens who originally voted to create CIRM to dispense $3 billion to fund stem cell research in California, and the patients and advocates …

CIRM-funded clinical trial aimed at blocking HIV/AIDS in people gets the go ahead

An innovative therapy using a patient’s own stem cells, modified to resist infection with the AIDS virus, has been given approval by the Food and Drug Administration (FDA) to begin a clinical trial in people. CIRM, California’s stem cell agency, is funding that trial.

USC hosts California stem cell agency’s tenth birthday bash

Few 10 year olds have brought 10 potential medical treatments into clinical trials. The California Institute for Regenerative Medicine (CIRM), however, is a truly exceptional 10 year old. In 2004, the people of California created CIRM to dispense $3 billion in voter-approved dollars to fund stem cell research in the state. Progress has been impressive. …

Kevin McCormack

Stay connected.